Introduction Although classic sensitizing mutations of epidermal growth factor receptor
(EGFR) are positive predictive markers for EGFR tyrosine kinase inhibitors (TKIs) in lung …

EGFR mutations was significantly higher (vs. rare EGFR mutations; 71% vs. 37%; p= 0.039).
Patients with classic or sensitizing rare (G719x and L861Q) EGFR mutations had …

Introduction Although classic sensitizing mutations of epidermal growth factor receptor
(EGFR) are positive predictive markers for EGFR tyrosine kinase inhibitors (TKIs) in lung …

Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in
Lung Adenocarcinoma - Repository of the Academy's Library MTA KIK REAL Home About …

Introduction Although classic sensitizing mutations of epidermal growth factor receptor
(EGFR) are positive predictive markers for EGFR tyrosine kinase inhibitors (TKIs) in lung …

Methods Eight hundred and fourteen lung adenocarcinoma patients with KRAS and/or
EGFR mutation analyses for TKI therapy indication were identified. Six hundred and forty …

Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations
in Lung Adenocarcinoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

EGFR mutations was significantly higher (vs. rare EGFR mutations; 71% vs. 37%; p= 0.039).
Patients with classic or sensitizing rare (G719x and L861Q) EGFR mutations had …

Introduction: Although classic sensitizing mutations of epidermal growth factor receptor
(EGFR) are positive predictive markers for EGFR tyrosine kinase inhibitors (TKIs) in lung …

INTRODUCTION:: While classic sensitizing mutations of epidermal growth factor receptor
(EGFR) are positive predictive markers for EGFR tyrosine kinase inhibitors (TKIs) in lung …